These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 17225279

  • 1. Anti-HIV agents. Dueling nukes: AZT + 3TC vs. tenofovir + FTC.
    TreatmentUpdate; 2005; 17(5):5-7. PubMed ID: 17225279
    [No Abstract] [Full Text] [Related]

  • 2. Meeting notes from ICAAC. Tenofovir + emtricitabine vs. AZT + 3TC.
    Feinberg J.
    AIDS Clin Care; 2005 Jan; 17(1):7. PubMed ID: 15717373
    [No Abstract] [Full Text] [Related]

  • 3. Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
    Masquelier B, Neau D, Boucher S, Lavignolle-Aurillac V, Schrive MH, Recordon-Pinson P, Ragnaud JM, Fleury H.
    Antivir Ther; 2006 Jan; 11(6):827-30. PubMed ID: 17310827
    [Abstract] [Full Text] [Related]

  • 4. Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.
    Martin A, Bloch M, Amin J, Baker D, Cooper DA, Emery S, Carr A.
    Clin Infect Dis; 2009 Nov 15; 49(10):1591-601. PubMed ID: 19842973
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with nevirapine combined with tenofovir plus emtricitabine or lamivudine-containing regimens in HIV-infected subjects.
    Smith DE, Chan DJ, Maruszak H, Jeganathan S.
    Int J STD AIDS; 2011 Apr 15; 22(4):228-30. PubMed ID: 21515757
    [Abstract] [Full Text] [Related]

  • 6. The art of managing human immunodeficiency virus infection: a balancing act.
    Reiss P.
    Clin Infect Dis; 2009 Nov 15; 49(10):1602-4. PubMed ID: 19842978
    [No Abstract] [Full Text] [Related]

  • 7. Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
    Jenny-Avital ER.
    N Engl J Med; 2006 Jun 08; 354(23):2506-8; author reply 2506-8. PubMed ID: 16764056
    [No Abstract] [Full Text] [Related]

  • 8. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
    Redfield RR, Morrow JS.
    Clin Infect Dis; 2008 Oct 01; 47(7):984-5. PubMed ID: 18778234
    [No Abstract] [Full Text] [Related]

  • 9. Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
    Sax PE.
    AIDS Clin Care; 2005 Jan 01; 17(1):6-7. PubMed ID: 15717372
    [No Abstract] [Full Text] [Related]

  • 10. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
    Reijnders JG, Janssen HL.
    J Hepatol; 2008 Mar 01; 48(3):383-6. PubMed ID: 18191272
    [No Abstract] [Full Text] [Related]

  • 11. Minor emtricitabine intolerance in treatment-stable patients switched from tenofovir/lamivudine to a fixed-dose combination of tenofovir/emtricitabine (Truvada).
    Palacios R, Terrón A, Hidalgo A, Rivero A, Santos J, SIMVA Group.
    J Antimicrob Chemother; 2008 Feb 01; 61(2):462-3. PubMed ID: 18156608
    [No Abstract] [Full Text] [Related]

  • 12. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov 01; 22(11):918. PubMed ID: 19043840
    [No Abstract] [Full Text] [Related]

  • 13. Anti-HIV agents. Abacavir--as good as AZT?
    TreatmentUpdate; 2003 Oct 01; 15(6):3-4. PubMed ID: 17216861
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children.
    Moolasart P, Likanonsakul S.
    Southeast Asian J Trop Med Public Health; 2002 Jun 01; 33(2):280-7. PubMed ID: 12236426
    [Abstract] [Full Text] [Related]

  • 15. Abacavir/3TC vs. tenofovir/FTC: interim results from ACTG 5202.
    Albrecht H.
    AIDS Clin Care; 2008 Apr 01; 20(4):28. PubMed ID: 19271262
    [No Abstract] [Full Text] [Related]

  • 16. [First line therapy. Tenofovir DF/emtricitabine--the potent backbone].
    MMW Fortschr Med; 2008 Apr 28; 150 Spec No 1():12-4. PubMed ID: 19024908
    [No Abstract] [Full Text] [Related]

  • 17. Tenofovir regimen compared with Combivir.
    AIDS Patient Care STDS; 2005 Jan 28; 19(1):59-60. PubMed ID: 15700398
    [No Abstract] [Full Text] [Related]

  • 18. New once-daily HIV combination better tolerated.
    Expert Rev Anti Infect Ther; 2004 Dec 28; 2(6):826. PubMed ID: 15566325
    [No Abstract] [Full Text] [Related]

  • 19. The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.
    Winston A, McAllister J, Amin J, Cooper DA, Carr A.
    HIV Med; 2005 May 28; 6(3):191-7. PubMed ID: 15876286
    [Abstract] [Full Text] [Related]

  • 20. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Rey D, Hoen B, Chavanet P, Schmitt MP, Hoizey G, Meyer P, Peytavin G, Spire B, Allavena C, Diemer M, May T, Schmit JL, Duong M, Calvez V, Lang JM.
    J Antimicrob Chemother; 2009 Feb 28; 63(2):380-8. PubMed ID: 19036752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.